Evidence map›Paper›PMID 39835274›Full record

ArticleFrontiers in cellular and infection microbiology2024

Optimizing the production and efficacy of antimicrobial bioactive compounds from

Zifang Shang, Vipasha Sharma, Liu Pai, Tarun Kumar, Sandip Patil

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zifang Shang *Guangdong Engineering Technological Research Centre of Clinical Molecular Diagnosis and Antibody Drugs, Meizhou Academy of Medical Sciences, Meizhou People's Hospital (Huangtang Hospital), Meizhou, China.
Vipasha Sharma *Department of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India.
Liu PaiDepartment of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China.
Tarun KumarMkelly Biotech Pvt Ltd., Mohali, Punjab, India.
Sandip PatilMkelly Biotech Pvt Ltd., Mohali, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The rise of antibiotic-resistant pathogens has intensified the search for novel antimicrobial agents. This study aimed to isolate Methods: Soil samples were collected from local regions, processed, and analysed for Streptomyces strains isolation using morphological characteristics and molecular identification through 16S rRNA gene PCR assay. Antimicrobial activity was assessed against Results: A total of 25 distinct Conclusion: This study confirmed that

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsStreptomycesBacillus subtilisCandida albicansCulture MediaDNA, BacterialDrug Resistance, Multiple, BacterialEscherichia coliMicrobial Sensitivity TestsRNA, Ribosomal, 16SSoil MicrobiologySpectroscopy, Fourier Transform InfraredStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsCulture MediaDNA, BacterialRNA, Ribosomal, 16Santibiotic resistanceantimicrobial activitybioactive compoundsoptimizationStreptomyces kanamyceticus

Identifiers

PMID39835274
PMCPMC11743287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.